Aidy
Free coverage checker

Does your insurance cover your IBD medication?

Pick your insurer, medication, and condition to see typical coverage, prior authorization, and step therapy requirements, all based on publicly available formulary policies.

Check your coverage

Covered, prior auth required

Yes, Skyrizi is typically covered by Aetna, with prior authorization

Most Aetna commercial plans cover Skyrizi (risankizumab) for Crohn's disease, but your prescriber must submit clinical documentation before the plan will pay. Approval is common when criteria are met.

Policy as of Jul 2026
Prior authorization

Required

Prescriber submits clinical documentation; decision times vary by plan, urgency, and how complete the submission is.

Step therapy

None

No fail-first in the cited policy; individual plan formularies can still add rules.

Typical placement

Varies by plan

CPB 1009 is a medical-benefit policy and does not set a pharmacy tier

Line of business:
Commercial
Reauthorization:
Continuation requires documented clinical response; no universal 12-month interval stated
PA criteria:
Moderate-to-severe active Crohn's disease; prescribed by or in consultation with a gastroenterologist; TB screening; labeled route and dosing; precertification required under CPB 1009. Continuation requires documented clinical benefit. No fail-first is listed in the base policy, though a plan's pharmacy formulary may add rules.
Exception path:
None specified
Scope:
Aetna commercial medical-benefit CPB 1009 for IV induction; SC maintenance is separate.
Read the full guide: Does Aetna cover Skyrizi for Crohn's disease?Coverage varies by plan. Always confirm with your insurer.

The access landscape for Crohn's disease

How restrictive each major insurer's standard commercial formulary is, per medication. Select any cell to see the details above.

  • Prior auth
  • PA + step therapy
  • Brand excluded / off formulary
  • Varies by local plan
Aetna
Anthem
Blue Cross Blue Shield
Cigna
Kaiser Permanente
UnitedHealthcare
Entyviovedolizumab
Humiraadalimumab
Omvohmirikizumab
Rinvoqupadacitinib
Skyrizirisankizumab
Stelaraustekinumab
Tremfyaguselkumab

Standard commercial policies; last reviewed Jul 2026. Coverage depends on your exact plan, employer group, state, and whether the drug is infused (medical benefit) or self-injected (pharmacy benefit). Blue Cross Blue Shield coverage is set by independent local Blue companies, and Kaiser Permanente details reflect Kaiser Northwest policy documents. This tool summarizes publicly available policies and is for informational purposes only. It is not medical or insurance advice.